Researcher Profiles

Return to member profile

Kim M. Hirshfield, MD, PhD

Publications since 2011

Rodriguez-Rodriguez, L. Hirshfield, K. M. Rojas, V. DiPaola, R. S. Gibbon, D. Hellmann, M. Isani, S. Leiser, A. Riedlinger, G. M. Wagreich, A. Ali, S. M. Elvin, J. A. Miller, V. A. Ganesan, S. Use of comprehensive genomic profiling to direct point-of-care management of patients with gynecologic cancers. Gynecol Oncol, 141:2-9, . (PMID: 27016222)

Santorelli, M. L. Steinberg, M. B. Hirshfield, K. M. Rhoads, G. G. Bandera, E. V. Lin, Y. Demissie, K. Effects of breast cancer on chronic disease medication adherence among older women. Pharmacoepidemiol Drug Saf, In process, . (PMID: 26875432)

Paratala, B. S. Dolfi, S. C. Khiabanian, H. Rodriguez-Rodriguez, L. Ganesan, S. Hirshfield, K. M. Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers. Biomark Cancer, 8:1-14, . (PMID: 26917980)

Ganguly, B. Dolfi, S. C. Rodriguez-Rodriguez, L. Ganesan, S. Hirshfield, K. M. Role of Biomarkers in the Development of PARP Inhibitors. Biomark Cancer, 8:15-25, . (PMID: 26997874, PMCID: PMC4786099)

Marbach-Bar, N. Bahat, A. Ashkenazi, S. Golan-Mashiach, M. Haimov, O. Wu, S. Y. Chiang, C. M. Puzio-Kuter, A. Hirshfield, K. M. Levine, A. J. Dikstein, R. DTIE, a novel core promoter element that directs start site selection in TATA-less genes. Nucleic Acids Res, In process, . (PMID: 26464433)

Llanos, A. A. Chandwani, S. Bandera, E. V. Hirshfield, K. M. Lin, Y. Ambrosone, C. B. Demissie, K. Associations between sociodemographic and clinicopathological factors and breast cancer subtypes in a population-based study. Cancer Causes Control, In process, . (PMID: 26376894)

Teh, J. L. Shah, R. La Cava, S. Dolfi, S. C. Mehta, M. S. Kongara, S. Price, S. Ganesan, S. Reuhl, K. R. Hirshfield, K. M. Karantza, V. Chen, S. Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells. Breast Cancer Res Treat, In process, . (PMID: 25859923)

Stein, M. N. Hirshfield, K. M. Zhong, H. Singer, E. A. Ali, S. M. Ganesan, S. Response to Crizotinib in a Patient with MET-mutant Papillary Renal Cell Cancer After Progression on Tivantinib. Eur Urol, In process, . (PMID: 25457019)

Dolfi, S. C. Jager, A. V. Medina, D. J. Haffty, B. G. Yang, J. M. Hirshfield, K. M. Fulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugs. Cancer Lett, 350:52-60, . (PMID: 24747123)

Hirshfield, K. M. Ganesan, S. Triple-negative breast cancer: molecular subtypes and targeted therapy. Curr Opin Obstet Gynecol, 26:34-40, . (PMID: 24346128)

Tian, S. Hirshfield, K. M. Jabbour, S. K. Toppmeyer, D. Haffty, B. G. Khan, A. J. Goyal, S. Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients. Front Oncol, 4:277, . (PMID: 25346912, PMCID: PMC4191171)

Glod, J. Song, M. Sharma, A. Tyagi, R. Rhodes, R. H. Weissmann, D. J. Roychowdhury, S. Khan, A. Kane, M. P. Hirshfield, K. Ganesan, S. DiPaola, R. S. Rodriguez-Rodriguez, L. Next generation sequencing as an aid to diagnosis and treatment of an unusual pediatric brain cancer. J Pers Med, 4:402-411, . (PMID: 25563358)

Mehta, M. S. Dolfi, S. C. Bronfenbrener, R. Bilal, E. Chen, C. Moore, D. Lin, Y. Rahim, H. Aisner, S. Kersellius, R. D. Teh, J. Chen, S. Toppmeyer, D. L. Medina, D. J. Ganesan, S. Vazquez, A. Hirshfield, K. M. Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes. PLoS One, 8:e69851, . (PMID: 23922822, PMCID: PMC3724883)

Tedeschi, P. M. Markert, E. K. Gounder, M. Lin, H. Dvorzhinski, D. Dolfi, S. C. Chan, L. L. Qiu, J. Dipaola, R. S. Hirshfield, K. M. Boros, L. G. Bertino, J. R. Oltvai, Z. N. Vazquez, A. Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells. Cell Death Dis, 4:e877, . (PMID: 24157871, PMCID: PMC3920946)

Dolfi, S. C. Chan, L. L. Qiu, J. Tedeschi, P. M. Bertino, J. R. Hirshfield, K. M. Oltvai, Z. N. Vazquez, A. The metabolic demands of cancer cells are coupled to their size and protein synthesis rates. Cancer Metab, 1:20, . (PMID: 24279929)

Chandran, U. Hirshfield, K. M. Bandera, E. V. The role of anthropometric and nutritional factors on breast cancer risk in African-American women. Public Health Nutr, 15:738-748, . (PMID: 22122844)

Haffty, B. G. Goyal, S. Kulkarni, D. Green, C. Vazquez, A. Schiff, D. Moran, M. S. Yang, Q. Ganesan, S. Hirsfield, K. M. Evaluation of Single Nucleotide Polymorphisms (SNPs) in the p53 Binding Protein 1 (TP53BP1) Gene in Breast Cancer Patients Treated With Breast-Conserving Surgery and Whole-Breast Irradiation (BCS + RT). Int J Radiat Oncol Biol Phys, 80:385-391, . (PMID: 20646866)

Vazquez, A. Kulkarni, D. Grochola, L. F. Bond, G. L. Barnard, N. Toppmeyer, D. Levine, A. J. Hirshfield, K. M. A genetic variant in a PP2A regulatory subunit encoded by the PPP2R2B gene associates with altered breast cancer risk and recurrence. Int J Cancer, 128:2335-2343, . (PMID: 20669227)

Mehta, M. S. Vazquez, A. Kulkarni, D. A. Kerrigan, J. E. Atwal, G. Metsugi, S. Toppmeyer, D. L. Levine, A. J. Hirshfield, K. M. Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes. Breast Cancer Res Treat, 125:861-868, . (PMID: 20658316)

Rao, M. Khan, A. J. Moran, M. S. Hirshfield, K. M. Ganesan, S. Haffty, B. G. Goyal, S. Clinicopathologic Presentation of Asian-Indian American (AIA) Women with Stage 0, I & II Breast Cancer. J Immigr Minor Health, 13:42-48, . (PMID: 20563645)

Das, K. M. Kong, Y. Bajpai, M. Kulkarni, D. Geng, X. Mishra, P. Banerjee, D. Hirshfield, K. Transformation of benign barrett's epithelium by repeated acid and bile exposure over 65 weeks: A novel in-vitro model. Int J Cancer, 128:274-282, . (PMID: 20309934)